TCM Biotech International Corp.

Summary

TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases. The company's products include osteoarthritis treatment products, osteoporosis treatment preparations, iron preparations, antivirals preparations, urinary system treatment products, expectorants/mucolytic agents, antineoplastics agents, anti-hypertensive preparations, and anti-diabetic preparations, anti-adhesion systems, pellefeel wound care systems, Philips non-invasive ventilators, and others, as well as medical devices and functional foods. It is also developing TCM-800B for the treatment of hepatitis B; PTX-9908 for the treatment of liver cancer; and PTD-9908 for the anti-PD-1 treatment. The company sells its products in Taiwan, the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines, China, and internationally. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.